Tag: Editas
Editas Medicine to Present Preclinical Data Demonstrating Advancements in In Vivo...
CAMBRIDGE, Mass., May 01, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that...